Who is sponsoring RACE X?

RACE X is sponsored by University Medical Center Groningen.

What condition does RACE X study?

RACE X studies Fibrillation, Atrial, Atrial Cardiomyopathy.

What drugs are being tested in RACE X?

Interventions: Pulmonary vein isolation, Pharmacological rhythm management.

What is the status of RACE X?

RACE X is currently RECRUITING.

Last reviewed 2024-10-18 · How we verify

Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men (RACE X)

NCT06200311 NA RECRUITING

The goal of clinical trial is to compare AF ablation to pharmacological rhythm management (being rate or rhythm control) in AF patients with signs of atrial cardiomyopathy (as defined by left atrial volume index \>34 ml/m2) The main objective it aims to answer is to determine whether AF ablation compared to pharmacological rhythm management in ACMP patients with AF reduces the incidence of the composite primary endpoint of CV death and first CV hospitalization/urgent visit.

Details

Lead sponsor	University Medical Center Groningen
Phase	NA
Status	RECRUITING
Enrolment	604
Start date	Thu Jul 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jul 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Fibrillation, Atrial
Atrial Cardiomyopathy

Interventions

Pulmonary vein isolation
Pharmacological rhythm management

Countries

Netherlands